Dabur India Limited on Thursday reported 5.9 per cent fall in consolidated net profit at Rs 342 crore in April-June quarter as against Rs 363 crore in the corresponding period of last year.
Furthermore, Dabur also continued to gain market share across all key categories like Chyawanprash, Toothpaste and Packaged Juices & Nectars, during the quarter.
|Q1FY21 (in crores)||Q1FY20 (in crores)||Change|
Domestic FMCG business saw a decline of 6.9 per cent due to the coronavirus lockdown in April and international business witnessed a fall of 21.6 per cent. As a result, overall volume declined 9.7 per cent.
“We entered the Covid-19 crisis from a position of strength. We were growing at a steady pace when the pandemic brought business to a standstill,” said Chief Executive Officer Mohit Malhotra.
Dabur said during the quarter the company introduced a record number of new products and variants anchored on the consumer need for health, immunity and hygiene.
“The quarter saw our new products record sales of over Rs 100 crores,” the company said.
“Amid this challenging business environment, we quickly revamped our portfolio to meet the growing consumer need for quality preventive healthcare, personal hygiene and household hygiene products while enhancing the production of our existing Ayurvedic immunity boosters like Dabur Chyawanprash and Dabur Honey.”
In conclusion, Dabur is confident that its sales will increase as people will be looking for healthy alternative and immune boosters, as more states ease the lockdown restrictions.